cs.CVOct 29, 2026

Segment Anything Pancreas: A Unified MRI Segmentation Model for Pancreatic Cancer Radiotherapy

Authors: Zach Eidex, Mojtaba Safari, Kundan Thind, Parag J. Parikh, Zhen Tian, Xiaofeng Yang

Organizations: Department of Computer Science and Radiation Oncology, Emory University, Atlanta, GA, USA · Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA · Department of Radiation Oncology, Henry Ford Health, Detroit, MI, USA

Abstract

Background: Limited tumor annotations and incomplete labels across MRI datasets hinder unified segmentation of pancreatic tumors and organs at risk (OARs) for MRI-guided radiotherapy. Purpose: We propose Pancreas-MedNeXt, a unified model that segments the whole pancreas, its subregions, tumors, and surrounding OARs from one MRI volume. Methods: The model uses a shared MedNeXt encoder-decoder with supervised whole-pancreas and subregion pretraining, followed by multitask fine-tuning. Three output heads predict the pancreatic subregions, tumor, and OARs (stomach, duodenum, kidneys). An annotation-aware loss allows training on partially labeled data without treating unannotated structures as background. Pancreas and tumor were evaluated by three-fold cross-validation on 142 PANTHER patients (92 diagnostic, 50 MR-Linac), subregions and OARs on Cyst-X and AMOS test sets, and pancreas and OARs on 33 external T1-weighted TotalSegmentator scans. Comparisons with nnU-Net, MedNeXt, VISTA3D, and Swin UNETR used the Dice similarity coefficient (DSC) with paired bootstrap 95% CIs. Results: Pancreas-MedNeXt achieved the highest mean pancreas and tumor DSC on diagnostic and MR-Linac MRI. Tumor DSC was 58.41% and 42.55%, exceeding task-specific MedNeXt by 4.94 (95% CI: 0.28-9.45) and 5.89 (95% CI: 2.37-9.72) percentage points, respectively. Whole-pancreas DSC was 85.73% and 70.66%. Pretraining improved head, body, and tail DSC by 2.01, 3.00, and 3.78 percentage points over training from scratch. It also achieved the highest DSC for the pancreas, duodenum, and right kidney on AMOS, and for all five organs on external MRI, exceeding the next-best method by 4.92-8.85 percentage points.Conclusion: A single Pancreas-MedNeXt model segments tumors, pancreatic subregions, and OARs on diagnostic and MR-Linac MRI, which could streamline contouring for pancreatic cancer radiotherapy.

Figures & tables

Explore similar work

Sep 11, 2026

Unified CT and MRI Pancreas Segmentation for Label-Efficient Cross-Modality Subregion Transfer

Robust medical image segmentation across imaging modalities is challenging because of large differences in appearance and intensity distributions. Models trained on a single modality often show substantial performance drops when applied to unseen domains. In this work, we develop a unified 3D pancreas segmentation framework that applies domain-adversarial learning to 4,604 heterogeneous CT and MRI scans to learn anatomical representations. A shared nnU-Net encoder-decoder is trained for whole-pancreas segmentation, with a latent domain discriminator encouraging CT-MRI feature alignment. The learned encoder is subsequently transferred to pancreatic head-body-tail segmentation using limited MRI-only subregion annotations. An average Dice score of 87.31% on the in-distribution test set and Dice scores ranging from 84.20% to 88.09% across external OOD datasets were achieved in whole pancreas segmentation. Dice scores of 80.53% on MRI and 83.05% on CT were achieved for downstream subregion segmentation, without using CT subregion annotations. These results demonstrate that a unified anatomical representation can support both cross-modality pancreas segmentation and label-efficient downstream transfer.
Apr 20, 2026

CrossPan: A Comprehensive Benchmark for Cross-Sequence Pancreas MRI Segmentation and Generalization

Automatic pancreas segmentation is fundamental to abdominal MRI analysis, yet deep learning models trained on one MRI sequence often fail catastrophically when applied to another-a challenge that has received little systematic investigation. We introduce CrossPan, a multi-institutional benchmark comprising 1,386 3D scans across three routinely acquired sequences (T1-weighted, T2-weighted, and Out-of-Phase) from eight centers. Our experiments reveal three key findings. First, cross-sequence domain shifts are far more severe than cross-center variability: models achieving Dice scores above 0.85 in-domain collapse to near-zero (<0.02) when transferred across sequences. Second, state-of-the-art domain generalization methods provide negligible benefit under these physics-driven contrast inversions, whereas foundation models like MedSAM2 maintain moderate zero-shot performance through contrast-invariant shape priors. Third, semi-supervised learning offers gains only under stable intensity distributions and becomes unstable on sequences with high intra-organ variability. These results establish cross-sequence generalization-not model architecture or center diversity-as the primary barrier to clinically deployable pancreas MRI segmentation. Dataset and code are available at https://crosspan.netlify.app/.
Sep 8, 2026

TRIUNE-Net: Harmonizing Scale, Shape, and Efficiency in Pancreatic Tumor Segmentation

Pancreatic tumor segmentation in 3D CT volumes is challenged by extreme scale variability across both the pancreas and tumor, and highly irregular tumor morphology. While recent advances have pushed segmentation performance, existing methods do not explicitly address these challenges and come at the cost of excessive computational complexity, limiting their practicality in resource-constrained clinical environments. We propose TRIUNE-Net, a lightweight unified architecture that harmonizes scale, shape, and efficiency through three synergistic innovations. A multi-scale context aggregation module with stage-adaptive dilated convolutions enables the model to reason across the broad range of anatomical scales present in both organs. A serial linear-deformable attention mechanism combines large effective receptive fields with shapeadaptive deformable convolutions to capture irregular, non-convex tumor morphologies. Finally, an information-preserving downsampling module replaces conventional max pooling entirely, retaining all spatial information while adding negligible parameters, preventing small tumors from being discarded before they can be recognized. On both the MSD Pancreas and NVD Pancreas datasets, TRIUNE-Net achieves state-of-theart results with only 5.86 M parameters and no external pre-training, outperforming all baselines across all key tumor metrics. Specifically, it surpasses the next-best model by 0.45% in tumor Dice, 6.0 points in F1 score, 6.6 points in sensitivity, and 3.4 points in precision, simultaneously reflecting its ability to suppress both missed tumors and false alarms in clinically realistic conditions. Our code is available at: https://github.com/abdora-ai/TRIUNE-Net